Drocourt; Daniel

Patent Applications and Registrations

Patent applications and USPTO patent grants for Drocourt; Daniel.The latest application filed is for "anti-hla monoclonal chimeric immunoglobulin, process and kit employing such a monoclonal chimeric immunoglobulin".

Company Profile

1.12.11

Drocourt; Daniel - Saint Orens de Gameville FR
Drocourt; Daniel - Toulouse FR
Drocourt; Daniel - St-Orens de Gameville N/A FR
DROCOURT; Daniel - Saint Orens FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Anti-HLA monoclonal chimeric immunoglobulin, method and kit implementing such a monoclonal chimeric immunoglobulin Grant 10,705,076 - Blancher , et al.	2020-07-07
Anti-hla Monoclonal Chimeric Immunoglobulin, Process And Kit Employing Such A Monoclonal Chimeric Immunoglobulin App 20190135924 - Blancher; Antoine ; et al.	2019-05-09
Combined Use Of A Chemotherapeutic Agent And A Cyclic Dinucleotide For Cancer Treatment App 20170340658 - VERNEJOUL; Fabienne ; et al.	2017-11-30
Anti-HLA monoclonal chimeric immunoglobulin, process and kit employing such a monoclonal chimeric immunoglobulin Grant 9,637,538 - Blancher , et al. May 2, 2	2017-05-02
Conjugated TLR7 and/or TLR8 and TLR2 agonists Grant 9,567,336 - Vernejoul , et al. February 14, 2	2017-02-14
Compositions of TLR7 and/or TLR8 agonists conjugated to lipids Grant 9,458,184 - Vernejoul , et al. October 4, 2	2016-10-04
Somatostatin 2 receptor (sst2), deoxycytidine kinase (dck) and uridine monophosphate kinase (umk) pancreatic gene therapy Grant 9,364,494 - Buscail , et al. June 14, 2	2016-06-14
Conjugated TLR7 and/or TLR8 and TLR2 polycationic agonists Grant 9,295,732 - Lioux , et al. March 29, 2	2016-03-29
Combination Products For Treating Cancer App 20150190480 - BUSCAIL; LOUIS ; et al.	2015-07-09
Anti-hla Monoclonal Chimeric Immunoglobulin, Method And Kit Implementing Such A Monoclonal Chimeric Immunoglobulin App 20150037819 - Blancher; Antoine ; et al.	2015-02-05
Conjugated TLR7 and/or TLR8 and TLR2 polycationic agonists App 20140242108 - LIOUX; Thierry ; et al.	2014-08-28
Conjugated Tlr7 And/or Tlr8 And Tlr2 Agonists App 20140141033 - VERNEJOUL; Fabienne ; et al.	2014-05-22
Novel Compositions Of Tlr7 And/or Tlr8 Agonists Conjugated To Lipids App 20130336996 - VERNEJOUL; Fabienne ; et al.	2013-12-19
Anti-hla Monoclonal Chimeric Immunoglobulin, Process And Kit Employing Such A Monoclonal Chimeric Immunoglobulin App 20130288387 - BLANCHER; Antoine ; et al.	2013-10-31
CPG-free gene for a new secreted reporter protein Grant 8,435,777 - Reynes , et al. May 7, 2	2013-05-07
Lyophilized Plasmid/dna Transfection Reagent Carrier Complex App 20110008894 - RAVET; Emmanuel ; et al.	2011-01-13
Combination Products For Treating Cancer App 20100222418 - Buscail; Louis ; et al.	2010-09-02
Synthetic genes and bacterial plasmids devoid of CpG Grant 7,244,609 - Drocourt , et al. July 17, 2	2007-07-17
Synthetic genes and bacterial plasmids devoid of cpg App 20040219677 - Drocourt, Daniel ; et al.	2004-11-04
Application of antibiotics of the phleomycin family as selection agent in the field of genetic engineering Grant 5,118,620 - Armau , et al. * June 2, 1	1992-06-02
Application of antibiotics of the phleomycin family as selection agent in the field of genetic engineering Grant 5,021,344 - Armau , et al. June 4, 1	1991-06-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.